Capturing the fluid dynamics of blood

Mohammed Abdul Hannan Hazari
Professor & Head, Department of Physiology,
Deccan College of Medical Sciences,
DMRL 'X' Road, Kanchanbagh, Hyderabad-500058,
Telangana, India.


Article History
Submitted: 2018-11-06
Accepted: 2018-11-07
Online: 2018-11-28
Print: 2018-11-28

Conflict of interest: None declared.

How to cite
Hazari MA. Hemorheology: Capturing the fluid dynamics of blood. Ann Med Physiol. 2018 Jul-Sep; 2(3):25-26. doi: 10.23921/amp.2018v2i3.15965

Scan QR Code

Full text

Rheology is the study of flow and deformation of materials under applied forces. It is primarily applicable to liquids but is also applicable to soft-solids, semi-solids and even solids under conditions in which they respond with plastic flow [1]. It includes the phenomena of flow of solids, liquids and gases; and particularly involves time-dependent behavior under the influence of stresses [2]. The application of rheology extends to materials having complex microstructure like mud, sludge, suspensions, polymers, silicates, body fluids, etc. Rheology describes the behavior especially of non-Newtonian fluids wherein viscosity changes with change in strain and flow velocity [1].

Flow is typically measured using shear stress (τ) i.e. stress component coplanar with the material cross section and strain rate (γ) i.e. deformation of material with respect to time. Viscosity (η) is calculated as the ratio between sheer stress and strain rate [3].

τ = Force applied Cross-sectional area of material

γ = Change in dimension Change in time

η = τ γ

Among body fluids, blood is the best example of non-Newtonian fluid. It is a non-homogenous fluid suspension having plasma with all its dissolved solutes acting as fluid base in which formed elements and large protein molecules are suspended.

Hemorheology is very peculiar as the formed elements have great flexibility and blood flows in compliant vessels. The viscosity is also optimal owing to presence of glycocalyx on the surface of the blood cells and the endothelium.

Blood flow almost all the time in most of the vascular tree is laminar (streamline) due to many factors inherent to components of blood and vessel walls. The probability of turbulence increases with increase in velocity of blood, increase in diameter of vessel and decrease in viscosity. Hyperdynamic circulation with increased turbulence may physically damage the endothelium. On the other hand, sluggishness (decrease velocity) of blood flow and increase viscosity predisposes to thrombus formation.

Studies have shown association of various disordered states with the changes in physical properties of blood [4]. Blood pressure increases with increase in blood viscosity [5]. Plasma viscosity and RBC aggregation showed significant association with cardiovascular disease (CVD) [5,6]. Increased hematocrit and fibrinogen resulting in increased blood viscosity may promote ischemic heart disease (IHD) and stroke [7]. Also rheological variables especially blood viscosity showed significant correlations with conventional cardiovascular risk factors like cigarette smoking, advancing age, hypertension, high body mass index and serum total cholesterol [8,9,10]. Increased plasma viscosity is associated with decreased cognitive ability in diabetes possibly by decreasing cerebral blood flow [11].

Now the question arises – ‘Do rheological variables play a causal role in disease?’. Rheology is an overlooked component of vascular disease [12]. The plausible pathophysiological mechanisms by which rheological variables might promote CVD are atherogenesis, thrombosis or perpetuation of ischemia. Increase in blood viscosity increases total peripheral resistance thereby raising blood pressure. It cannot be told with certainty that the association of rheological variables with CVD may be a causal relationship or a consequence or a mere coincidence and needs larger randomized controlled studies for confirmation [4]. However, the importance of the rheological measures in CVD cannot be ignored as raised blood viscosity leading to high vascular shear stress contributes to the site specificity of atherogenesis, rapid growth of atherosclerotic lesions and increases their propensity to rupture [13]. Therapeutic intervention in the form of statin administration targeting reduction in serum lipoproteins significantly reduced both plasma and blood viscosity [14]. Drugs like dihydropyridine calcium antagonists improve red blood cell deformability thereby improving blood rheology [15,16].

Therefore, enough evidence to show that the rheological parameters of blood should also be accounted for apart from hemocytometry and biochemistry in determining the risk and in the prognosis of a disease condition particularly in IHD and stroke. Hence, “capturing the fluid dynamics of blood” may play a considerable role in clinical medicine.


  1. Wikipedia. Rheology. Available from https://en.wikipedia.org/wiki/Rheology (Last accessed November 02, 2018)
  2. Eliades T, Zinelis S, Kim DG, Brantley WA. Structure/property relationships in orthodontic polymers. In: Eliades T, Brantley WA, editors. Orthodontic applications of biomaterials: A clinical guide. Chapter 2, Sawston, Cambridge: Woodhead Publishing, an imprint of Elsevier, 2017, pp.39-59. [Crossref]
  3. Struble LJ, Ji X. Rheology. In: Ramachandran VS, Beaudoin JJ, editors. Handbook of analytical techniques in concrete science and technology: Principles, techniques and applications. Chapter 9, Norwich, NY: William Andrew, an imprint of Elsevier, 2001, pp.333-367. [Crossref]
  4. Lowe GD. Blood rheology, haemostasis and vascular disease. In: Bloom AL, Forbes CD, Thomas DP, Tuddenham EG, editors. Haemostasis and Thrombosis, 3rd edn, Edinburgh: Churchill Livingstone, 1994, pp.1169–1188.
  5. Gori T, Wild PS, Schnabel R, Schulz A, Pfeiffer N, Blettner M, Beutel ME, Forconi S, Jung F, Lackner KJ, Blankenberg S, Münzel T. The distribution of whole blood viscosity, its determinants and relationship with arterial blood pressure in the community: cross-sectional analysis from the Gutenberg Health Study. Ther Adv Cardiovasc Dis. 2015 Dec; 9(6):354-65. [Pubmed] [Crossref]
  6. Woodward M, Rumley A, Tunstall-Pedoe H, Lowe GD. Associations of blood rheology and interleukin-6 with cardiovascular risk factors and prevalent cardiovascular disease. Br J Haematol. 1999 Feb; 104(2):246-57. [Pubmed] [Crossref]
  7. Lowe GD, Lee AJ, Rumley A, Price JF, Fowkes FG. Blood viscosity and risk of cardiovascular events: the Edinburgh Artery Study. Br J Haematol. 1997 Jan; 96(1):168-73. [Pubmed] [Crossref]
  8. Lowe GD, Smith WC, Tunstall-Pedoe HD, Crombie IK, Lennie SE, Anderson J, Barbenel JC. Cardiovascular risk and haemorheology – Results from the Scottish Heart Health Study and the MONICA project, Glasgow. Clin Hemorheology and Microcirculation 1988, 8(3-4):517-24. [Crossref]
  9. Lowe GD, Lee AJ, Rumley A, Smith WC, Tunstall‐Pedoe HD. Epidemiology of hematocrit, white cell count, red cell aggregation and fibrinogen: the Glasgow MONICA study. Clin Hemorheology and Microcirculation 1992; 12(4):535-44. [Crossref]
  10. Peters SA, Woodward M, Rumley A, Tunstall-Pedoe HD, Lowe GD. Plasma and blood viscosity in the prediction of cardiovascular disease and mortality in the Scottish Heart Health Extended Cohort Study. Eur J Prev Cardiol. 2017 Jan; 24(2):161-7. [Pubmed] [Crossref]
  11. Marioni RE, Deary IJ, Strachan MW, Lowe GD, Rumley A, Murray GD, Price JF. Blood rheology and cognition in the Edinburgh Type 2 Diabetes Study. Age Ageing. 2010 May; 39(3):354-9. [Pubmed] [Crossref]
  12. Kensey KR. Rheology: An overlooked component of vascular disease. Clin Appl Thrombosis / Hemostasis. 2003; 9(2):93-9.
  13. Cowan AQ, Cho DJ, Rosenson RS. Importance of blood rheology in the pathophysiology of atherothrombosis. Cardiovasc Drugs Ther. 2012 Aug; 26(4):339-48. [Pubmed] [Crossref]
  14. Lowe G, Rumley A, Norrie J, Ford I, Shepherd J, Cobbe S, Macfarlane P, Packard C. Blood rheology, cardiovascular risk factors, and cardiovascular disease: the West of Scotland Coronary Prevention Study. Thromb Haemost. 2000 Oct; 84(4):553-8. [Pubmed]
  15. Slonim A, Cristal N. Cardiovascular diseases, blood rheology, and dihydropyridine calcium antagonists. J Cardiovasc Pharmacol. 1992; 19 Suppl 3:S96-8. [Pubmed] [Crossref]
  16. Fujita J, Tsuda K, Takeda T, Yu L, Fujimoto S, Kajikawa M, Nishimura M, Mizuno N, Hamamoto Y, Mukai E, Adachi T, Seino Y. Nisoldipine improves the impaired erythrocyte deformability correlating with elevated intracellular free calcium-ion concentration and poor glycaemic control in NIDDM. Br J Clin Pharmacol. 1999 May; 47(5):499-506. [Pubmed] [Crossref]